The initial public offering of Asston Pharmaceuticals, a rapidly expanding exporter of healthcare and pharmaceutical products, opens for subscription today. The book-built issue is priced in the range of ₹115 to ₹123 per share, with a fixed lot size of 1,000 shares.
Comments
Post a Comment